Current and future immunotherapeutic approaches in pancreatic cancer treatment

Evolution of low HER2 expression between early and advanced-stage breast cancer

Gemcitabine treatment enhances HER2 expression in low HER2-expressing breast cancer cells and enhances the antitumor effects of trastuzumab emtansine

Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis